Insulin resistance, glucagon-like peptide-1 and factors influencing glucose homeostasis in neonates

Arch Dis Child Fetal Neonatal Ed. 2017 Mar;102(2):F162-F166. doi: 10.1136/archdischild-2015-309174. Epub 2016 Sep 2.

Abstract

Objectives: To explore the relationships between postmenstrual age (PMA), insulin, C-peptide, glucagon and blood glucose concentrations (BGCs) in preterm and term neonates. To compare glucagon-like peptide-1 (GLP-1) concentrations in fed versus never-fed neonates.

Design: Observational.

Setting: Dunedin Hospital Neonatal Intensive Care Unit, New Zealand.

Patients: Term or preterm euglycaemic neonates (102) receiving routine blood tests (343 samples).

Interventions: None: plasma was obtained from surplus samples from routine clinical care.

Main outcome measures: Insulin, C-peptide, GLP-1 and glucagon concentrations were measured in temporal association with BGC.

Results: Insulin and C-peptide concentrations were elevated in very preterm infants (PMA≤32 weeks) and decreased to term; this relationship persisted when BGCs were accounted for. Generalised linear mixed models showed that insulin:C-peptide ratio and insulin:BGC ratio decreased significantly with increasing PMA (p<0.001). GLP-1 increased following initial oral feeds regardless of PMA (p<0.001).

Conclusion: Preterm neonates exhibit insulin resistance in the absence of hyperglycaemia. Enteral feeds result in an increase in GLP-1. These factors are likely to contribute to the increased risk of hyperglycaemia in premature neonates (PMA<32 weeks).

Keywords: GLP-1; glucagon; hyperglycaemia; insulin; neonate.

Publication types

  • Observational Study

MeSH terms

  • Blood Glucose / metabolism*
  • C-Peptide / blood
  • Female
  • Glucagon / blood
  • Glucagon-Like Peptide 1 / blood*
  • Homeostasis / physiology
  • Humans
  • Infant, Newborn
  • Infant, Premature
  • Insulin / blood
  • Insulin Resistance / physiology*
  • Intensive Care Units, Neonatal
  • Male
  • New Zealand

Substances

  • Blood Glucose
  • C-Peptide
  • Insulin
  • Glucagon-Like Peptide 1
  • Glucagon